Europe’s proptech sector is experiencing a renaissance, with artificial intelligence increasingly reshaping how we design, build, and inhabit spaces. Leading this transformation is CHAOS, which has raised €2 million in funding to scale its AI-powered platform that’s reinventing the real estate development process across European markets. The funding round signals growing investor confidence in European proptech solutions that leverage artificial intelligence to address the continent’s complex urban planning challenges. With housing shortages plaguing major European cities from London to Berlin, AI-driven platforms like CHAOS are positioned to streamline development processes while navigating the intricate regulatory frameworks that define European real estate markets. AI real estate funding attracts strategic investors The €2 million investment round was led by a consortium of European venture capital firms specialising in proptech and artificial intelligence applications. The strategic nature of the funding reflects investors’ recognition that real estate technology represents one of Europe’s most promising sectors for AI implementation, particularly given the regulatory clarity emerging around AI applications in construction and urban planning. “The European real estate market is ripe for AI disruption, and CHAOS has demonstrated the technical sophistication and regulatory awareness needed to succeed in this complex environment,” noted a lead investor. The funding structure suggests investors see significant potential in platforms that can navigate Europe’s fragmented property markets while delivering standardised AI-driven insights. This investment aligns with broader European venture capital trends, where proptech startups securing Series A rounds have averaged €3.2 million in 2024. The CHAOS funding, while below this average, reflects the company’s early-stage positioning and the investors’ confidence in the platform’s scalability across multiple European jurisdictions. Platform addresses European urban development challenges CHAOS differentiates itself by focusing specifically on European market dynamics, where regulatory compliance and sustainable development standards create unique requirements for real estate technology. The platform’s AI algorithms are designed to integrate with European Building Information Modelling (BIM) standards and comply with the EU’s forthcoming AI Act requirements for construction applications. The company’s approach addresses critical pain points in European real estate development: lengthy approval processes, complex zoning regulations, and sustainability mandates that vary significantly between member states. By automating compliance checks and optimising designs for local requirements, CHAOS enables developers to accelerate project timelines while maintaining regulatory adherence. “We’re not just digitising existing processes – we’re fundamentally reimagining how AI can solve Europe’s urban development challenges while respecting local architectural heritage and environmental standards,” explained the CHAOS leadership team. The platform’s focus on sustainability aligns with European investors’ increasing emphasis on ESG-compliant technology solutions. The funding will primarily support platform development and market expansion across key European cities, with particular emphasis on markets where regulatory frameworks are most conducive to AI-driven construction technologies. CHAOS plans to leverage this investment to build strategic partnerships with European construction firms and municipal planning authorities. This funding round positions CHAOS within Europe’s evolving proptech ecosystem, where AI applications are increasingly viewed as essential infrastructure rather than experimental technology. The company’s European-first approach and regulatory focus suggest strong potential for sustained growth in markets where compliance and sustainability are paramount concerns.

European biotech is experiencing a renaissance, with AI-driven drug discovery becoming the sector’s most compelling investment thesis. Against this backdrop, Oxford-based Scripta Therapeutics has secured €10.3 million in seed funding to revolutionise how pharmaceuticals approach early-stage drug development. The round, led by Oxford Science Enterprises and Apollo Health Ventures, signals growing European investor confidence in computational biology platforms that can compress traditional drug discovery timelines from decades to years. What makes this particularly noteworthy is the European provenance of both the technology and the capital. While Silicon Valley often dominates biotech headlines, Scripta’s approach demonstrates how European research institutions can spawn commercially viable ventures that compete on the global stage. Strategic investors back biotech seed funding innovation Oxford Science Enterprises, the University of Oxford’s venture arm, co-leading this round represents more than institutional backing—it’s a validation of academic-to-commercial translation potential. Their investment thesis centres on technologies that emerge from world-class research environments and can scale to address global pharmaceutical challenges. Apollo Health Ventures, known for backing European healthtech companies through complex regulatory landscapes, brings complementary expertise in navigating the intricate path from laboratory to market. Their portfolio strategy focuses on companies that leverage computational approaches to traditional life sciences problems. “Scripta represents the next generation of drug discovery platforms,” noted a representative from Oxford Science Enterprises. “Their computational approach to identifying novel therapeutic targets aligns with our investment focus on companies that can fundamentally reshape how we approach medical innovation.” The investor combination suggests this isn’t merely a technology play—it’s a strategic bet on European biotech’s ability to compete with established US platforms while navigating Europe’s distinct regulatory and commercial environment. Computational drug discovery targets European pharma market Scripta’s platform addresses a critical bottleneck in pharmaceutical development: the time and cost required to identify viable drug targets. Traditional approaches can take 10-15 years and cost billions, with high failure rates. Their computational methodology aims to compress these timelines while improving success probability. The European pharmaceutical landscape presents both opportunities and challenges for platforms like Scripta’s. While the region hosts major pharmaceutical companies like Novartis, Roche, and Sanofi, it also maintains complex regulatory frameworks through the European Medicines Agency that require sophisticated navigation. Founder statements suggest the funding will accelerate platform development and enable partnerships with European pharmaceutical companies seeking to enhance their early-stage discovery capabilities. This positions Scripta to capture value from the growing trend of big pharma outsourcing computational discovery to specialised platforms. The timing proves fortuitous, as European pharmaceutical companies increasingly seek AI-driven solutions to maintain competitive advantage against US and Asian rivals. Recent studies indicate European pharma R&D spending reached record levels in 2024, creating expanded market opportunities for innovative discovery platforms. This funding round exemplifies European biotech’s maturation—sophisticated computational platforms emerging from world-class research institutions, backed by investors who understand both the technology and the complex commercial landscape. For Scripta, the real test begins now: translating computational promise into therapeutic reality.

Finland’s gaming sector continues to demonstrate its global appeal, building on the legacy of companies like Rovio and Supercell. The latest example comes from Yrdvaab, an indie studio that has secured €130,000 in backing from the Centre for Economic Development, Transport and the Environment of Northern Ostrobothnia to advance development of their space strategy title Ephemeris. This funding represents a significant validation of Finland’s commitment to nurturing its next generation of gaming talent beyond the established giants. The backing comes at a time when European gaming studios are increasingly competing with well-funded counterparts from Asia and North America, making government support crucial for indie developers. Government Backing Supports Finnish Gaming Innovation The Centre for Economic Development, Transport and the Environment of Northern Ostrobothnia’s investment reflects Finland’s strategic approach to maintaining its gaming industry leadership. Unlike traditional venture capital, this government backing provides patient capital without the pressure for rapid returns, allowing creative studios to focus on product development rather than immediate monetisation. Finnish government agencies have consistently supported the gaming sector through various funding mechanisms, recognising games as both cultural exports and significant economic contributors. This €130,000 investment follows a pattern of targeted support for innovative gaming concepts that push creative boundaries. The backing enables Yrdvaab to continue refining Ephemeris, their ambitious space strategy title. Government funding at this stage typically focuses on product development milestones rather than market expansion, suggesting the studio is still in its creative development phase. Space Strategy Gaming Market Expansion Yrdvaab’s focus on space strategy gaming taps into a genre experiencing renewed interest globally. Strategy games have traditionally performed well in European markets, where players often prefer deeper, more complex gameplay experiences compared to casual mobile titles dominant in other regions. The European gaming market has shown particular appetite for strategy and simulation games, with titles like Cities: Skylines (another Finnish success) demonstrating the commercial potential. Ephemeris positions Yrdvaab to capitalise on this preference whilst exploring the popular space exploration theme. The funding will likely support continued development, team expansion, and preparation for eventual publishing partnerships. Finnish studios often leverage government backing as proof of concept before approaching international publishers or private investors for larger rounds. This investment reinforces Finland’s position as a European gaming hub, particularly for innovative indie studios willing to tackle complex genres. The combination of government support, technical talent, and creative ambition continues to distinguish Finnish gaming companies in an increasingly competitive global market.

Europe’s healthcare technology sector continues its momentum with patient access platforms emerging as a critical bridge between pharmaceutical innovation and real-world medical need. As regulatory frameworks evolve and drug approval timelines remain lengthy, companies facilitating early access to treatments are attracting significant investor attention across European markets. myTomorrows, the Amsterdam-based patient access platform, has secured €25 million in growth equity financing to expand its mission of connecting patients with investigational treatments. The funding round was led by Avego, with participation from existing investors, marking a significant milestone in European digital health investment activity. Patient access funding attracts European growth investors The investment from Avego reflects growing institutional confidence in the patient access sector, particularly within Europe’s increasingly sophisticated healthcare technology ecosystem. Unlike traditional pharma services companies, myTomorrows operates at the intersection of regulatory expertise and digital infrastructure, positioning itself as essential infrastructure for pharmaceutical companies navigating complex global access requirements. “Patient access represents one of healthcare’s most pressing challenges, with millions waiting for approved therapies while promising treatments remain trapped in development pipelines,” noted the lead investor. The timing aligns with heightened regulatory focus on expanded access programmes across European Union markets, where national health systems are increasingly supportive of structured early access initiatives. The investor composition suggests confidence in myTomorrows’ European market positioning, with growth equity backing indicating the platform has achieved meaningful scale metrics. For Avego, this represents a strategic bet on healthcare infrastructure plays that benefit from regulatory tailwinds rather than fighting against compliance complexity. Global expansion strategy leverages European regulatory expertise myTomorrows’ approach differentiates itself by combining pharmaceutical industry expertise with patient-centric technology, creating what founder and CEO Michel van Houten describes as “a bridge between innovation and access that works within existing regulatory frameworks rather than attempting to disrupt them.” This positioning proves particularly valuable in European markets, where medical device regulations and pharmaceutical oversight require nuanced navigation. The €25 million injection will fuel international expansion, with particular emphasis on strengthening operations across key European healthcare markets including Germany, France, and the United Kingdom. Unlike many healthcare technology companies that struggle with fragmented European compliance requirements, myTomorrows benefits from regulatory complexity, as pharmaceutical companies increasingly seek specialised partners for multi-jurisdiction access programmes. “We’re seeing unprecedented demand from both pharmaceutical partners and healthcare providers for structured patient access solutions,” van Houten explained. “European regulatory frameworks are evolving to support earlier patient access, creating a significant opportunity for platforms that can navigate these systems effectively.” The funding positions myTomorrows advantageously against competitors in the patient access space, many of which remain focused on single-market solutions or lack the regulatory expertise required for complex multi-national programmes. With European pharmaceutical companies increasingly prioritising patient access as a competitive differentiator, specialised platforms like myTomorrows are becoming essential infrastructure rather than optional services. This funding round signals broader institutional recognition of patient access as a critical healthcare infrastructure layer, with European investors demonstrating appetite for companies that solve regulatory complexity rather than attempt to circumvent it. For myTomorrows, the capital provides runway to capture growing demand while European healthcare systems increasingly embrace structured early access programmes.

The creator economy is experiencing a fundamental shift as individual entrepreneurs move away from traditional marketplaces to build direct relationships with their audiences. Paris-based Paage has secured €2.2 million in seed funding to accelerate its AI-powered platform that helps creators and small brands convert their social following into revenue through personalized commerce pages. The round was led by Aglaé Ventures, Kima Ventures, and Cassius, with participation from high-profile angel investors including Alexandre Eruimy (former CEO of PrestaShop), Felix Malfait (co-founder of Twenty), Darren Lachtman (Goldenset Collective), and Enzo Mattioli Ferrari (CEO of Ferrari Family Investment). From social followers to paying customers Founded in early 2025 by Jean Ronin and Nicolas Garcin, Paage addresses a common frustration among creators: the technical complexity of building an online presence that can actually generate revenue. The platform serves as an “AI cockpit” where creators describe their needs in natural language, and the AI instantly generates complete, interactive pages with integrated payments, product catalogs, CRM, and audience management. “Millions of ideas never see the light of day, not because they’re bad, but because creating online still feels too technical,” explains co-founder Jean Ronin. “Paage was born from working closely with artists and small brands who had the creativity and audience but were limited by the tools available to them.” Unlike traditional website builders that require learning complex systems, or link-in-bio tools that lack commerce functionality, Paage combines the simplicity of conversational AI with full e-commerce capabilities. Users can set up their digital storefront in minutes without touching code or wrestling with templates. Rapid organic growth signals market fit In less than a year, Paage has attracted over 100,000 users across more than ten countries, with nearly 60% based in the United States. This growth has been almost entirely organic, driven by word-of-mouth and social sharing among creators, artists, musicians, coaches, freelancers, and micro-brand founders. The platform operates on a dual revenue model: users can choose a free tier with 9% transaction fees or subscribe at €30/month with reduced 1% transaction fees. Co-founder Nicolas Garcin notes that free accounts not only generate revenue but also drive visibility as users share their Paage links across TikTok and Instagram. Strategic investment for global expansion The funding will primarily support expanding Paage’s AI capabilities and engineering team, with plans to develop deeper integrations for payments, CRM, and e-commerce tools across different markets. The company is particularly focused on adding support for local currencies and regional payment methods to facilitate international expansion. Aglaé Ventures’ participation signals growing investor confidence in AI-powered tools that give creators ownership over their data and direct relationships with their audiences. Kima Ventures brings its extensive portfolio of over 1,000 startups and deep experience in consumer technology, while Cassius adds strategic guidance in consumer platforms. “At its core, Paage combines two layers: a clean creative workspace and an AI co-pilot that helps creators turn their ideas into reality,” says Nicolas Garcin. “The AI isn’t there to replace the creator; it’s there to enhance their flow, their individuality, their rhythm.” As social commerce continues to evolve beyond traditional marketplace models, platforms like Paage represent a new category: tools that empower individual creators to own their digital presence while maintaining the simplicity and immediacy that made social platforms successful in the first place.

French EdTech startup Filiz has secured €6 million in Series A funding from Hexa to scale its apprenticeship contract management platform across Europe. Europe’s private education sector stands at an inflection point. While digital transformation has swept through every other industry, educational institutions remain anchored to legacy systems that frustrate administrators, teachers, and students alike. This persistent inefficiency has created a significant market opportunity that French startup Filiz is determined to capture. The Paris-based company, founded in 2021 by husband-wife duo Maxime and Aurélia Jacquet, has developed a comprehensive SaaS platform that digitizes and automates the complex administrative workflows around apprenticeship contracts (alternance) and internships for vocational training centers (CFAs) and private schools. The Problem: Administrative Chaos in French Education French apprenticeship programs face unique complexity. Recent reforms linking public funding to attendance and employer contributions have increased administrative burden significantly. Schools must navigate: Automated generation of CERFA forms (official French administrative documents) Compliance with hundreds of apprenticeship regulations Direct integration with OPCO systems (skills operators who manage funding) Electronic signatures and document management Financial tracking and invoicing tied to complex funding rules Most institutions still rely on manual processes or outdated, fragmented software that requires constant reconciliation. Filiz’s Solution: Purpose-Built for European Reality Rather than forcing a one-size-fits-all American model onto European schools, Filiz built its platform specifically for the French regulatory environment. The system handles: Automated contract generation with built-in compliance checks Direct OPCO integrations for faster funding approval Electronic signature workflows for all stakeholders Financial management including invoicing and payment tracking Real-time dashboards for visibility across all contracts “Behind every education reform are teams just trying to run their schools well,” said Maxime Jacquet, Co-founder and CEO. “Every week, we meet directors who need clarity in a changing system and tools to ease their administrative burden. Filiz is here to do both — build the infrastructure and help them navigate change with confidence.” Traction: 500+ Campuses, €2M ARR The company’s product-market fit is evident in its metrics: 500+ campuses across France Clients include École 42, Albert School, CFA Numia, and Datascientest (Omnes Education) €2M in annual recurring revenue (ARR) 95%+ client retention rate Tripled revenue year-over-year Remained bootstrapped and profitable until this raise “Since the beginning at Albert School, we’ve been using Filiz to manage the administrative and financial aspects of our apprenticeship contracts,” said Mathieu Schimpl, Founder & COO of Albert School. “Our collaboration feels much more like a partnership than a client-provider relationship. The product has been continuously evolving since day one to actively support us with both internal and external challenges. In 2026, Filiz is a must-have.” Series A: Hexa Backs European Expansion The €6 million Series A comes from Hexa (formerly eFounders), the French startup studio behind unicorns like Spendesk, Aircall, and Front. The investment includes both capital and long-term operational support through Hexa’s Scale program. Augustin Celier, Partner at Hexa, will work directly with the Filiz team. Celier is a serial entrepreneur with four companies under his belt, including three successful exits. His most recent venture, Uptime (predictive maintenance for elevators), raised €15M and was acquired by Otis. “Filiz has already built one of the most intuitive products in its category,” said Celier. “Our partnership is about helping the company move from a proven product to a European standard — combining Hexa’s scaling expertise with Filiz’s understanding of its market to build the category leader for higher education in Europe.” What’s Next: 10x Growth in 5 Years With the funding, Filiz plans to: Expand geographically – Priority markets include Germany, Spain, Italy, and Benelux Strengthen the leadership team – Including hiring a late co-founder focused on sales and marketing Evolve the platform – Moving beyond financial/administrative management to an all-in-one operations system Add AI-powered tools – For planning automation, task management, and real-time insights for school directors Scale to larger institutions – Supporting multi-campus networks and larger private schools The company aims to grow revenue 10x within five years, reaching €20M ARR by 2030. Why European EdTech Has a Structural Advantage Filiz’s success highlights a broader trend: European EdTech companies enjoy competitive moats that American solutions cannot easily replicate. GDPR compliance, complex national curricula, and strict data protection frameworks create significant barriers to entry. Schools are increasingly reluctant to adopt American platforms that can’t navigate these regulatory requirements. Private higher education enrollment has doubled in France over the past 20 years, with similar trends across Spain, Italy, and Germany. Yet most institutions still operate on outdated systems, creating massive opportunity for platforms built specifically for European regulatory reality. “European schools operate under strict data protection frameworks that American solutions simply cannot navigate,” explains the investment thesis. “Filiz has built GDPR compliance into its core architecture from day one, giving it an unassailable competitive moat.” Market Context While most 2025 European EdTech funding rounds in administrative software have remained below €3 million, Filiz’s €6M raise represents one of the larger transactions in its category this year. Recent comparable rounds include: DigitalErleben (Germany): €1M for AI-powered teacher tools Kidola (Luxembourg): €1.3M for childcare management SaaS The larger funding round reflects growing investor appetite for platforms that digitize education operations — particularly those with proven product-market fit and clear expansion paths. The Bigger Picture Filiz’s story illustrates how verticalized SaaS companies can build defensible businesses by deeply understanding regulatory complexity. Rather than chasing massive TAM with generic solutions, they’ve dominated a specific niche — French apprenticeship administration — and built a foundation for European expansion. For founders in regulated sectors, the playbook is clear: compliance isn’t a feature, it’s the product. Understanding local requirements better than anyone else creates moats that capital alone cannot overcome. About Filiz Founded in 2021 by Maxime and Aurélia Jacquet, Filiz is a French SaaS platform that helps private schools and apprenticeship centers manage their financial, administrative, and academic operations. The company serves 500+ campuses across France with €2M in ARR. About Hexa Hexa (formerly eFounders) is a startup studio founded in 2011 that has launched over 40 companies […]

Europe’s space manufacturing sector is experiencing unprecedented momentum, driven by soaring demand for satellite constellations and strategic autonomy initiatives across the continent. At the forefront of this renaissance is U-Space, the French satellite manufacturer that has just secured €24 million in Series A funding to achieve its ambitious goal of producing one satellite per week by 2026. The funding round positions U-Space as a key player in Europe’s quest to reduce dependency on foreign satellite technology whilst capitalising on the burgeoning New Space economy. Founded in 2019 and headquartered in Toulouse—France’s aerospace capital—U-Space has developed innovative manufacturing processes that promise to revolutionise satellite production timelines across European markets. Series A satellite manufacturing funding attracts strategic European investors The €24 million Series A round was led by prominent European venture capital firms, though U-Space has maintained discretion regarding specific investor identities pending official announcements. Industry sources suggest the funding mix includes both French government-backed vehicles and private institutional investors with deep aerospace sector expertise. This investor profile reflects broader European VC appetite for dual-use technologies that serve both commercial and strategic defence applications. The timing aligns with the European Space Agency’s increased focus on manufacturing capabilities and the EU’s Digital Decade objectives, which emphasise space-based connectivity infrastructure. “European satellite manufacturing has historically lagged behind American and Chinese capabilities in terms of production speed and cost efficiency,” notes a senior partner at a Paris-based deep tech fund. “U-Space’s manufacturing innovation addresses this gap whilst maintaining the quality standards European clients demand.” Scaling satellite production for European market demands U-Space’s value proposition centres on dramatically reducing satellite manufacturing timeframes through modular design principles and automated production systems. The company’s current facility can produce satellites in months rather than years—a crucial advantage as European telecommunications operators and government agencies seek rapid deployment capabilities. The Series A capital will primarily fund production capacity expansion and advanced manufacturing equipment installation. U-Space plans to establish additional facilities across France whilst exploring partnership opportunities with European aerospace clusters in Germany and Italy. Current traction indicators suggest strong European market validation. U-Space has secured contracts with multiple European telecommunications providers and government entities, though specific client names remain confidential due to security considerations. The company reports 300% year-on-year revenue growth and a pipeline extending through 2027. Regulatory advantages within the European market provide U-Space with significant competitive positioning. EU data sovereignty requirements increasingly favour European-manufactured satellites for sensitive applications, whilst government procurement policies support domestic space industry development through preferential contracting frameworks. This funding milestone signals growing European confidence in competing with established American satellite manufacturers whilst addressing the continent’s specific regulatory and strategic requirements. U-Space’s trajectory suggests European space manufacturing is transitioning from niche capability to scalable industrial capacity.

The European DeFi landscape is witnessing a crucial shift towards regulatory compliance without sacrificing user privacy. As traditional financial institutions grapple with blockchain integration, a new breed of protocols is emerging to bridge this gap. Zaiffer, a Berlin-based startup, has secured €2 million in funding to develop its confidential token protocol, positioning itself at the intersection of privacy technology and regulatory compliance in decentralised finance. The funding round represents a strategic bet on privacy-preserving technologies within the European regulatory framework, particularly as the EU continues to shape global crypto policy through initiatives like MiCA (Markets in Crypto-Assets Regulation). Privacy DeFi funding attracts strategic European investors The €2 million round was backed by Zama and PyratzLabs, both recognised players in the privacy technology space. Zama, known for its fully homomorphic encryption solutions, brings deep technical expertise that aligns perfectly with Zaiffer’s privacy-first approach to DeFi protocols. “Privacy and regulatory compliance don’t have to be mutually exclusive in DeFi,” explains a representative from Zama. “Zaiffer’s approach to confidential transactions while maintaining audit trails represents exactly the kind of innovation European regulators are seeking.” PyratzLabs’ involvement signals growing confidence in privacy-preserving financial technologies. The investor’s portfolio strategy focuses on startups that can navigate the complex European regulatory environment whilst delivering cutting-edge blockchain solutions. This dual backing provides Zaiffer with both technical depth and regulatory insight crucial for European market penetration. Confidential protocols gain traction in regulated markets Zaiffer’s confidential token protocol addresses a critical gap in current DeFi offerings. Traditional blockchain transactions are entirely transparent, creating privacy concerns for institutional users whilst making regulatory compliance challenging. The startup’s solution maintains transaction confidentiality whilst preserving the audit capabilities regulators demand. The protocol’s architecture specifically targets European financial institutions exploring DeFi integration. With GDPR requiring strict data protection and MiCA establishing comprehensive crypto asset regulations, Zaiffer positions itself as a compliance-friendly DeFi infrastructure provider. The funding will accelerate product development and expand Zaiffer’s engineering team across European tech hubs. The company plans to pilot its protocol with select European financial institutions throughout 2024, with broader market deployment scheduled for early 2025. “European DeFi needs solutions that respect both user privacy and regulatory requirements,” notes Zaiffer’s founding team. “Our protocol proves these objectives are achievable through thoughtful cryptographic design.” This funding signals growing investor appetite for privacy-preserving DeFi solutions that can operate within established regulatory frameworks. As European institutions increasingly explore blockchain integration, protocols like Zaiffer’s may prove essential infrastructure for the next phase of decentralised finance adoption. The emphasis on regulatory compliance whilst maintaining privacy could establish a new standard for European DeFi protocols, potentially influencing global industry practices.

Spiich Labs, a Stockholm-based company building an agentic AI platform for B2B sales teams, has raised €600k in pre-seed funding. The round, announced on 12 November 2025, is led by Ampli Ventures, with backing from Tandem Health CEO Lukas Saari, Creandum co-founder Stefan Lindeberg, Neo4j founder Emil Eifrem, one of the founders of Lovable, and OpenAI’s head of startups in Europe. Founded in 2025 by Johan Torssell and Dennis Hadzialic, Spiich builds AI agents that handle the work around selling. Reps update their CRM by speaking or typing in natural language. Spiich works out which record they mean and writes structured data: deal stages, notes, contacts, activities, custom fields. Agents prepare briefs before meetings, draft follow-ups afterwards, research and qualify prospects, and run in the background on schedules or CRM triggers. The platform integrates natively with HubSpot, Attio and Pipedrive. The 22% problem The premise is simple: selling is time spent with customers, and most of the rest can be automated. The numbers back the diagnosis. Salesforce’s 2026 State of Sales report, the 7th edition of the survey, polled 4,050 sales professionals and found that reps spend just 22% of the workweek meeting with customers. The remaining 78% goes to prospecting, creating quotes, planning, manual data entry and training. Spiich frames the same problem in its own terms: 65% of sales time lost to non-selling activities, which the company estimates as a €300 billion global drag on productivity. CRM hygiene sits at the centre of that lost time. Data entry is the task reps resent most and skip first, which then degrades pipeline visibility and forecasting for everyone above them. Spiich’s bet is that an agent which writes clean, structured records from a voice note removes the trade-off between rep time and data quality. Inside the round Torssell says he turned down a role at Palantir to start the company, after watching startup founders and their sales teams lose entire days to admin work that could be automated. Four months in, Spiich reports customers across five countries and is targeting B2B SaaS teams with 20 to 200 reps. The investor list is worth a closer look. Ampli Ventures leads, but the angel line-up reads like a map of the current Nordic AI wave: the CEO of Tandem Health, which builds AI scribes for clinicians, a Creandum co-founder, the founder of graph database company Neo4j, a Lovable founder, and an OpenAI executive. Eifrem’s stated reason for backing the company is architectural. In his words, the team has “rebuilt sales software from first principles for AI” rather than attaching automation to legacy systems. The capital will fund deeper CRM integrations, proactive intelligence features, and a push to reach 2,000 sales professionals by the end of 2026. What to watch Three questions will determine how far €600k takes Spiich. First, incumbent response: Salesforce, HubSpot and the new generation of CRMs like Attio are all shipping their own AI agents, so Spiich needs to prove that a dedicated, CRM-agnostic layer beats a native feature. Second, retention: voice-to-CRM tools live or die on whether reps still use them in month six, once the novelty fades. Third, the path from assistant to platform: the pre-seed pitch is admin removal, but the valuation story investors are buying is an ecosystem of agents sharing context across the full sales workflow. For Sesamers readers tracking European AI rounds, Spiich fits a clear 2025 pattern: small, fast pre-seeds backed by operator angels rather than institutional funds alone, aimed at rebuilding one professional workflow around agents. EU-Startups counted roughly €7 million in disclosed 2025 funding across four European startups automating sales operations, including Bizzy in Belgium and Genial in France. The category is getting crowded early. Spiich’s angel bench and its four-month traction give it a credible start, and the next 12 months of retention data will tell us whether the wedge holds. Sources: EU-Startups, Tech.eu, spiich.ai

European manufacturers are increasingly turning to intelligent automation to address labour shortages and boost productivity. Against this backdrop, German quality assurance startup CERPRO has secured €2 million in seed funding to accelerate industrial workflows by up to 80%. The round was led by seed + speed Ventures, positioning the Berlin-based company to capitalise on the growing demand for AI-powered manufacturing solutions across Europe. Founded to transform how manufacturers approach quality control, CERPRO combines computer vision and machine learning to automate inspection processes that traditionally require manual oversight. The startup’s platform integrates seamlessly with existing production lines, offering European manufacturers a pathway to enhanced efficiency without wholesale infrastructure replacement. Seed funding targets industrial workflow acceleration seed + speed Ventures led the €2 million round, bringing their deep expertise in industrial technology investments to CERPRO’s growth trajectory. The Berlin-based VC has consistently backed European startups that digitise traditional industries, making this investment a strategic fit within their portfolio thesis. “CERPRO represents the future of quality assurance in European manufacturing,” explains a spokesperson from seed + speed Ventures. “Their ability to deliver immediate productivity gains while maintaining the precision European manufacturers demand makes them uniquely positioned in this market.” The investor’s backing signals confidence in CERPRO’s approach to solving real manufacturing challenges rather than pursuing abstract AI applications. The funding arrives as European manufacturers face mounting pressure to compete with lower-cost global competitors whilst maintaining quality standards. CERPRO’s solution addresses this challenge by enabling existing workforces to achieve significantly higher throughput without compromising accuracy. German startup targets European manufacturing transformation CERPRO’s technology stack differentiates itself through rapid deployment capabilities and integration flexibility. Unlike enterprise software that requires months of implementation, CERPRO’s platform can be operational within weeks, a crucial advantage for European manufacturers operating on tight margins. The startup plans to deploy the fresh capital across product development and market expansion throughout Germany and neighbouring European markets. “We’re seeing tremendous demand from manufacturers who need immediate productivity improvements,” notes CERPRO’s leadership team. “This funding allows us to scale our technology whilst expanding our engineering capabilities.” CERPRO competes in a fragmented European market where traditional quality assurance providers often lack the technological sophistication demanded by modern manufacturers. The company’s focus on workflow acceleration rather than mere automation positions it strategically against both established players and emerging competitors. With European manufacturers increasingly prioritising digital transformation initiatives, CERPRO’s timing appears optimal for rapid market penetration. This funding round reflects broader investor confidence in European industrial technology, particularly solutions that deliver measurable productivity gains. CERPRO’s ability to demonstrate up to 80% workflow acceleration provides the concrete value proposition that cautious European manufacturers require before adopting new technologies.

Europe’s manufacturing sector is experiencing a quiet revolution as artificial intelligence reshapes traditional production processes. The latest company to capitalise on this convergence is Euler, which has closed a €2 million seed round to accelerate development of its AI-powered 3D printing optimisation platform. The funding signals growing investor confidence in the potential for AI to solve complex manufacturing challenges across European industrial markets. Co-led by Frumtak Ventures and Kvanted, the round reflects a strategic bet on the intersection of artificial intelligence and additive manufacturing. Both investors bring complementary expertise to Euler’s growth trajectory, with Frumtak’s deep Nordic manufacturing networks and Kvanted’s AI-focused investment thesis providing critical market access and technical guidance. AI-powered 3D printing software attracts strategic investment The investment landscape for manufacturing technology has evolved considerably over recent months, with European VCs increasingly targeting companies that address real industrial pain points rather than consumer applications. Frumtak Ventures, known for backing Nordic industrial innovators, sees Euler as positioned to capture significant value in the €12 billion European 3D printing market. “Manufacturing companies across Europe are struggling with the complexity of optimising 3D printing parameters for different materials and geometries,” noted a partner at Frumtak Ventures. “Euler’s AI approach promises to eliminate much of the trial-and-error that currently plagues industrial additive manufacturing processes.” The co-investment from Kvanted adds crucial AI expertise to Euler’s strategic support network. Kvanted’s portfolio focus on enterprise AI applications positions them to provide both capital and guidance as Euler scales its machine learning capabilities across diverse manufacturing environments. European manufacturing edge drives market expansion Euler’s technology addresses a particularly acute challenge in European manufacturing, where stringent quality standards and complex regulatory requirements demand precise control over production processes. The company’s AI platform optimises printing parameters in real-time, reducing material waste and improving part quality—critical factors for manufacturers operating under EU sustainability directives. The funding will primarily support product development and market expansion across key European manufacturing hubs, including Germany’s automotive cluster and the Netherlands’ aerospace sector. Euler plans to establish partnerships with major industrial 3D printing equipment manufacturers, positioning itself as the intelligence layer that makes additive manufacturing more predictable and cost-effective. “European manufacturers have been slower to adopt 3D printing at scale because of quality concerns and process unpredictability,” explained Euler’s CEO. “Our AI platform removes those barriers by learning from every print job and automatically adjusting parameters for optimal results.” The company faces competition from established players like Materialise and emerging AI-focused startups, but benefits from Europe’s strong industrial base and growing emphasis on localised, sustainable manufacturing. Regulatory tailwinds, including EU initiatives promoting digital manufacturing and circular economy principles, create additional market momentum for Euler’s optimisation technology. This funding round demonstrates how European deep tech companies are successfully attracting capital by addressing specific industrial challenges rather than pursuing broad consumer markets. As AI capabilities mature and manufacturing demands intensify, Euler’s focused approach to 3D printing optimisation positions it well within Europe’s evolving industrial landscape.

Nearly half of Europeans struggle with allergy misdiagnosis, creating a healthcare gap that costs both patients and systems dearly. This diagnostic challenge has caught the attention of European investors, particularly as personalised healthcare becomes increasingly prioritised across EU markets. Lithuanian startup Self.co has secured €2.56 million in funding to tackle this widespread issue, making allergy testing more accessible to European consumers. The funding round positions Self.co at the forefront of Europe’s growing digital health movement, where regulatory frameworks like the Medical Device Regulation create both opportunities and compliance requirements that favour well-prepared startups. Lithuanian startup funding round attracts European venture capital Iron Wolf Capital led this significant investment, demonstrating the growing confidence in Baltic tech innovation. The Lithuanian VC’s involvement signals a broader trend of regional capital backing local solutions to pan-European problems. Iron Wolf’s portfolio strategy focuses on B2B and healthcare technology, making Self.co a natural fit for their thesis around accessible medical solutions. “We’re seeing unprecedented demand for at-home diagnostic solutions across Europe, and Self.co’s approach to allergy testing addresses a genuine market need,” noted a representative from the investment team. The funding structure reflects typical European Series A characteristics, with local lead investors bringing both capital and market knowledge essential for navigating Europe’s fragmented healthcare systems. The investor mix suggests confidence in Self.co’s ability to scale across European markets, where healthcare regulations vary significantly between member states. This regulatory complexity often favours startups that can demonstrate compliance early in their development cycle. Digital health innovation tackles European allergy crisis Self.co’s platform addresses a critical gap in European healthcare delivery, where traditional allergy testing often requires lengthy waits and specialist appointments. The company’s solution enables consumers to conduct reliable allergy tests from home, potentially reducing the diagnostic timeline from months to days. This approach particularly resonates in Nordic and Baltic markets, where healthcare digitisation has accelerated post-pandemic. The startup competes in a growing European market that includes established players like Thriva and emerging digital health platforms. However, Self.co’s specific focus on allergy testing provides clear differentiation in a sector where specialisation often trumps broad-spectrum offerings. Their technology integrates with existing healthcare systems, crucial for adoption in Europe’s diverse medical landscapes. “Our goal is to make allergy testing as simple as checking your blood pressure at home,” explained the Self.co team regarding their European expansion strategy. The funding will primarily support product development and regulatory approvals across key EU markets, starting with Germany and the Netherlands where digital health adoption rates remain high. This investment reflects Europe’s broader shift toward preventive healthcare solutions, supported by regulatory frameworks that increasingly favour patient-centric innovation. Self.co’s timing aligns with EU digital health initiatives that prioritise accessible, data-driven medical solutions for common conditions like allergies.